Skip to main content
SpringerLink
Log in

Comparative Study of Serum Copper, Iron, Magnesium, and Zinc in Type 2 Diabetes-Associated Proteinuria

  • Published:
Biological Trace Element Research Aims and scope Submit manuscript

Abstract

Trace element (TE) disturbances are well noted in type 2 diabetes mellitus (T2DM) and its associated complications. In present study, the effect of proteinuria on serum copper (Cu), iron (Fe), magnesium (Mg), and zinc (Zn) in T2DM patients with and without proteinuria was seen. Total subjects were aged between 30 and 90 years; 73 had proteinuria, 76 had T2DM with proteinuria, 76 had T2DM, and 75 were controls. Serum Cu(II), Fe(III), Mg(II), and Zn(II) were assayed by inductively coupled plasma optical emission spectrometer (ICP-OES). Urinary albumin estimation was performed by turbidimetric method. Other biochemical parameters were analyzed by ROCHE Module COBAS 6000 analyzer. Statistical analysis was performed using analysis of variance (ANOVA) at P < 0.0001 followed by t test. Pearson correlation was applied to estimate the effect of proteinuria on TE. Serum Cu(II) level was increased in T2DM patients with proteinuria while Fe(III) was found elevated in T2DM (P < 0.0001) compared to control groups. Zn(II) and Mg(II) were significantly low in proteinuria, T2DM with proteinuria, and T2DM (P < 0.0001) compare to controls. Serum Cu(II) showed strong positive association with albumin creatinine ratio (ACR) in T2DM with proteinuria group and T2DM group (P < 0.01). Fe(III) was positively and Zn(II) was negatively associated with ACR at P < 0.10, in T2DM with proteinuria group. Mg(II) was negatively linked with ACR P < 0.01 in proteinuria, T2DM with proteinuria, and T2DM group. TE were observed more disturbed in T2DM with proteinuria group, thus considered to be the part of T2DM routine checkup and restricts the disease towards its progression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. World Health Organization (2013) Diabetes, fact sheet 312. http://www.who.int/mediacentre/factsheets/fs312/en/

  2. International Diabetes Federation (2013) The IDF diabetes atlas, 6th edn. International Diabetes Federation, Brussels, Belgium

    Google Scholar 

  3. Koda-Kimble MA, Carlisle BA (1995) Diabetes mellitus. In: Young LY, Koda-Kimble MA, Kradjan WA, Guglielmo BJ (eds) Applied therapeutics: the clinical use of drugs, 6th edn. Applied Therapeutics, Inc, Vancouver (WA), pp 481–485

    Google Scholar 

  4. Friederich M, Hansell P, Palm F (2009) Diabetes, oxidative stress, nitric oxide and mitochondria function. Curr Diabetes Rev 5:120–144

    Article  CAS  PubMed  Google Scholar 

  5. Cheng Z, Tseng Y, White MF (2010) Insulin signaling meets mitochondria in metabolism. Trends Endocrinol Metab 21:589–598

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  6. Larsen GL, Henson PM (1983) Mediators of inflammation. Annu Rev Immunol 1:335–359

    Article  CAS  PubMed  Google Scholar 

  7. Deshpande AD, Hayes MH, Schootmann M (2008) Epidemiology of diabetes and diabetes related complications. Phys Ther 88(11):1254–1264

    Article  PubMed Central  PubMed  Google Scholar 

  8. Narayan KM, Boyle JP, Giess LS (2006) Impact of recent increase in incidence on future diabetes burden. U.S. 2005–2050. Diabetes Care 29:2114–2116

    Article  PubMed  Google Scholar 

  9. Gall MA, Hougaard P, Borch JK, Parving HH (1997) Risk factors for development of incipient and overt diabetic nephropathy in patients with non insulin dependent diabetes mellitus: prospective, observational study. BMJ 314:783–788

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  10. Ravid M, Brosch D, Ravid SD, Levy Z, Rachmani R (1998) Main risk factors in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure and hyperglycemia. Arch Intern Med 158:998–1004

    Article  CAS  PubMed  Google Scholar 

  11. Caramori ML, Gross JL, Pecis M, Azevedo MJ (1999) Glomerular filtration rate, urinary albumin excretion rate and blood pressure changes in normoalbuminuric normotensive type 1 diabetes patients: an 8 year follow up study. Diabetes Care 22:1512–1516

    Article  CAS  PubMed  Google Scholar 

  12. Pecis M, Azevedo MJ, Gross JL (1994) Chicken and fish diet reduces glomerular hyperfiltration in IDDM patients. Diabetes Care 17:665–672

    Article  CAS  PubMed  Google Scholar 

  13. Riley MD, Dweyr T (1998) Microalbuminuria is positively associated with usual dietary saturated fat intake and negatively associated with usual dietary protein intake in people with insulin dependent diabetes mellitus. Am J Clin Nutr 67:50–57

    CAS  PubMed  Google Scholar 

  14. Vriese AS, Verbeuren TJ, Van DV (2000) Endothelial dysfunction in diabetes. Br J Pharmacol 130:963–974

    Article  PubMed Central  PubMed  Google Scholar 

  15. Du XL, Eldestein D, Dimmeler S (2001) Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Invest 108:1341–1348

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  16. Deckert T, Feld RB, Borch JK (1989) Albuminuria reflects widespread vascular damage. Steno Hypothesis 32:219–226

    CAS  Google Scholar 

  17. Chiarelli F, Gasperi S, Marchovecchio MZ (2009) Role of growth factor in diabetic kidney disease. Horm Metab Res 41(8):585–593

    Article  CAS  PubMed  Google Scholar 

  18. Rask MC, King GL (2010) Kidney complications; factors that protect the diabetic vasculature. Nat Med 16(1):40–41

    Article  Google Scholar 

  19. Ziyadeh FN (2004) Mediators of diabetic renal disease: the case for TGF beta as the major mediator. J Am Soc Nephrol 15(1):55–57

    Article  Google Scholar 

  20. Viktorínová A, Toserová E, Krizko M, Duracková Z (2009) Altered metabolism of copper, zinc, and magnesium is associated with increased levels of glycated hemoglobin in patients with diabetes mellitus. Metabolism 58:1477–1482

    Article  PubMed  Google Scholar 

  21. Ferns G, Lamb D, Taylor A (1997) The possible role of copper ions in atherogenesis: the blue janus. Atherosclerosis 133:139–152

    Article  CAS  PubMed  Google Scholar 

  22. World Health Organization (1999) Definition, diagnosis, and classification of diabetes mellitus and its complications, report of a WHO consultation part 1: diagnosis and classification of diabetes mellitus. World Health Organization, Geneva, Switzerland

    Google Scholar 

  23. Adsen A, Gitlin JD (2007) Copper deficiency. Curr Opin Gastroenterol 23:187–192

    Article  Google Scholar 

  24. Walter RM, Uriu-Hare JY, Olin KL, Oster MH, Anawalt BD, Critchfield JW, Keen CL (1991) Copper, zinc, manganese, and magnesium status and complications of diabetes mellitus. Diabetes Care 14:1050–1056

    Article  PubMed  Google Scholar 

  25. Real J, Bermego A, Ricart W (2002) Cross-talk between iron metabolism and diabetes. Diabetes 51:2348–2354

    Article  Google Scholar 

  26. Ganz T, Nemeth E (2006) Iron imports. IV. Hepcidin and regulation of body iron metabolism. Am J Physiol Gastrointest Liver Physiol 290(2):199–203

    Article  Google Scholar 

  27. Kazi TG, Afridi HI, Kazi N, Jamali MK, Arain MB, Jalban IN, Kandhro GA (2008) Copper, chromium, manganese, iron, nickel, and zinc levels in biological samples of diabetes mellitus patients. Biol Trace Elem Res 122:1–18

    Article  CAS  PubMed  Google Scholar 

  28. Ferńandez-Real J, Engel WR, Arroyo E et al (1998) Serum ferritin as a component of the insulin resistance syndrome. Diabetes Care 21:62–68

    Article  PubMed  Google Scholar 

  29. Jiang R, Manson JE, Meigs JB, Ma J, Rifai N, Hu FB (2004) Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. JAMA 291(6):711–717

    Article  CAS  PubMed  Google Scholar 

  30. Paolisso G, Scheen A, D’Onofrio F, Lefebvre P (1990) Magnesium and glucose homeostasis. Diabetologia 33:511–514

    Article  CAS  PubMed  Google Scholar 

  31. Vincent JB (2000) Quest for the molecular mechanism of chromium action and its relationship to diabetes. Nutr Rev 58(3):67–72

    Article  CAS  PubMed  Google Scholar 

  32. Tosiello L (1996) Hypomagnesemia and diabetes mellitus: a review of clinical implications. Arch Intern Med 156(11):1143–1148

    Article  CAS  PubMed  Google Scholar 

  33. Afridi HI, Kazi TG, Kazi N, Jamali MK, Arain MB, Jalbani N, Sarfaraz RA, Shah A, Kandhro GA, Shah AQ (2008) Potassium, calcium, magnesium, and sodium levels in biological samples of hypertensive and non-hypertensive diabetes mellitus patients. Biol Trace Elem Res 124(3):206–224

    Article  CAS  PubMed  Google Scholar 

  34. Chausmer A (1998) Zinc, insulin and diabetes. J Am Coll Nutr 17(2):109–115

    Article  CAS  PubMed  Google Scholar 

  35. Kinlaw WB, Levine AS, Morley JE, Silvis SE, McClain CJ (1983) Abnormal zinc metabolism in type II diabetes mellitus. Am J Med 75:273–277

    Article  CAS  PubMed  Google Scholar 

  36. Stephen AM, Alex N, Mark M (2012) Zinc transporters, mechanisms of action and therapeutic utility: implications for type 2 diabetes mellitus. J Nutr Metab. doi:10.1155/2012/173712

    Google Scholar 

  37. American Diabetes Association (2001) Clinical practice recommendations. Diabetes Care 24:69–72

    Article  Google Scholar 

  38. Hogg RJ, Portmann RJ, Milliner D, Lemley KV, Eddy A, Ingelfinger J (2000) Evaluation and management of proteinuria and nephrotic syndrome in children: recommendations from a pediatric nephrology panel established at the national kidney foundation conference on proteinuria, risk, assessment, detection, elimination (PARADE). Pediatrics 105:1242–1249

    Article  CAS  PubMed  Google Scholar 

  39. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma. Clin Chem 18:499–502

    CAS  PubMed  Google Scholar 

  40. Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31–41

    Article  CAS  PubMed  Google Scholar 

  41. Powers MA (1987) Handbook of diabetes nutritional management. Aspen Publishers Inc, Maryland

    Google Scholar 

  42. Nerlich AG, Sauer U, Kolm-Litty V, Wagner E, Koch M, Schleicher ED (1998) Expression of glutamine:fructose-6-phosphate amido transferase in human tissues: evidence for high variability and distinct regulation in diabetes. Diabetes 47:170–178

    Article  CAS  PubMed  Google Scholar 

  43. Gupta A, Lutsenko S (2009) Human copper transporters: mechanism, role in human diseases and therapeutic potential. Future Med Chem 1:1125–1142

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  44. Talaei A, Jabari S, Bigdeli MH, Farahani H, Siavash M (2011) Correlation between microalbuminuria and urinary copper in type two diabetic patients. Ind J Endocrinol Metab 15(4):316–319

    Article  CAS  Google Scholar 

  45. Aguilar MV, Saavedra P, Arrieta FJ et al (2007) Plasma mineral content in type-2 diabetic patients and their association with the metabolic syndrome. Ann Nutr Metab 51:402–406

    Article  CAS  PubMed  Google Scholar 

  46. Zheng Y, Li XK, Wang Y, Cai L (2008) The role of zinc, copper and iron in the pathogenesis of diabetes and diabetic complications: therapeutic effects by chelators. Hemoglobin 32:135–145

    Article  CAS  PubMed  Google Scholar 

  47. Serdar MA, Bakir F, Hasimi A et al (2009) Trace and toxic element patterns in nonsmoker patients with noninsulin dependent diabetes mellitus, impaired glucose tolerance, and fasting glucose. Int J Diabetes Dev Countries 29:35–40

    Article  Google Scholar 

  48. Babalola OO, Ojo LO, Akinleye AO (2007) Status of the levels of lead and selected trace elements in type 2 diabetes mellitus patients in Abeokuta, Nigeria. Afr J Biochem Res 1(7):127–131

    Google Scholar 

  49. Mumtaz A, Anees M, Fatima S, Ahmed R, Ibrahim M (2011) Serum zinc and copper levels in nephrotic syndrome patients. Pak J Med Sci 27(5):1173–1176

    Google Scholar 

  50. Teitiker T, Paydas S, Yuregir G, Sagliker Y (1993) Trace elements alteration in chronic hemodialysis patients with chronic renal failure and proteinuria. J Biol Inorg Chem 6:33–35

    Google Scholar 

  51. Joshi A, Ratnu KS, Joshi KC, Vyas PC (1993) Trace elements in nephrotic syndrome and chronic renal failure. Indian J Nephrol 3:48–50

    Google Scholar 

  52. Yasmin H, Neggers JR, William W (2001) Dressler the relationship between zinc and copper status and lipid levels in African-Americans. Biol Trace Elem Res 79:1–13

    Article  Google Scholar 

  53. Osredkar J, Sustar N (2011) Copper and zinc biological role and significance of copper/zinc imbalance. J Clinic Toxicol. doi:10.4172/2161-0495.S3-001

    Google Scholar 

  54. Meenakshi P, Uma G, Nayyar SB (2013) Comparative study of serum zinc, magnesium and copper levels among patients of type 2 diabetes mellitus with and without microangiopathic complications. Innov J Med Health Sci 3(6):274–278

    Google Scholar 

  55. Hershko C, Peto TE, Weatherall DJ (1988) Iron and infection. Br Med J 296:660–664

    Article  CAS  Google Scholar 

  56. Adams PC, Reboussin DM, Barton JC et al (2005) Hemochromatosis andiron-overload screening in a racially diverse population. N Engl J Med 352(17):1769–1778

    Article  CAS  PubMed  Google Scholar 

  57. Worwood M (2002) Serum transferrin receptor assays and their application. Ann Clin Biochem 39(3):221–230

    Article  CAS  PubMed  Google Scholar 

  58. Harrison MD, Jones EJ, Dameron CE (1999) Copper chaperones: function, structure and copper binding properties. J Biol Inorg Chem 4:145–153

    Article  CAS  PubMed  Google Scholar 

  59. Pufahl RA, O’Halloran TV (1999) Mechanisms of copper chaperone proteins. In: Sarkar B (ed) Metals and genetics. Plenum Publishing Corporation, New York

    Google Scholar 

  60. Wintergerst ES, Maggini S, Hornig DH (2007) Contribution of selected vitamins and trace elements to immune function. Ann Nutr Metab 51:301–323

    Article  CAS  PubMed  Google Scholar 

  61. Wong PC, Waggoner D, Subramaniam JR, Tessarollo L, Bartnikas TB (2000) Copper chaperone for superoxide dismutase is essential to activate mammalian Cu/Zn superoxide dismutase. Proc Natl Acad Sci 97:2886–2891

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  62. Eshed I, Elis A, Lishner M (2001) Plasma ferritin and type 2 diabetes mellitus: a critical review. Endocr Res 27:91–97

    Article  CAS  PubMed  Google Scholar 

  63. Wilson JG, Lindquist JH, Grambow SC et al (2003) Potential role of increased iron stores in diabetes. Am J Med Sci 325(6):332–339

    Article  PubMed  Google Scholar 

  64. Mueller AS, Pallauf J (2006) Compendium of the anti diabetic effects of supra nutritional selenate doses: in vivo and in vitro investigations with type II diabetic db/db mice. J Nutr Biochem 17(8):548–560

    Article  CAS  PubMed  Google Scholar 

  65. Pickup JC, Matttock MB, Chusney GD, Burt D (1997) NIDDM as a disease of the innate immune system: association of acute phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 40:1286–1292

    Article  CAS  PubMed  Google Scholar 

  66. Resnick L, Altura BT, Gupta RK, Laragh JH, Alderman MH, Altura BM (1993) Intracellular and extracellular magnesium depletion in type 2 (non-insulin dependent) diabetes mellitus. Diabetologia 36:767–70

    Article  CAS  PubMed  Google Scholar 

  67. Herbert SC, Desir G, Giebisch G (2005) Molecular diversity and regulation of renal potassium channels. Physiol Rev 85(1):319–371

    Article  Google Scholar 

  68. Pham PT, Pham SV, Miller JM, Pham PT (2007) Hypomagnesemia in patients with type 2 diabetes. Clin J Am Soc Nephrol 2(2):366–373

    Article  CAS  PubMed  Google Scholar 

  69. Ma J, Folsom AR, Melnick SA et al (1995) Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: the ARIC study. J Clin Epidemiol 48(7):927–940

    Article  CAS  PubMed  Google Scholar 

  70. Corsonello A, Lentile R, Buemi M, Cucinotto D, Mauro VN, Macaione S et al (2000) Serum ionized magnesium levels in type 2 diabetic patients with microalbuminuria or clinical proteinuria. Am J Nephrol 20:187–92

    Article  CAS  PubMed  Google Scholar 

  71. Gurfinkel D (1988) Role of magnesium in metabolism. Magnesium 7:249–261

    Google Scholar 

  72. Nosnwu AC, Usoro AO (2006) Glycemic control and serum and urinary levels of zinc and magnesium in diabetes in Calabar, Nigeria. Pak J Nutr 5(1):75–78

    Article  Google Scholar 

  73. Walter RM, Uriu-Hare OJY et al (1991) Copper, zinc, manganese and magnesium status and complications of diabetes mellitus. Diabetes Care 11:1050–1056

    Article  Google Scholar 

  74. Tripathy S, Sumathi S, BhupalRaj G (2004) Mineral nutritional status of type 2 diabetic subjects. Int J Diabetes Dev Countries 24:27–28

    Google Scholar 

  75. Chambers EC, Heshka S, Gallagher D et al (2006) Serum magnesium and type-2 diabetes in African Americans and Hispanics: a New York Cohort. J Am Coll Nutr 25:509–513

    Article  CAS  PubMed  Google Scholar 

  76. Masood N, Baloch GH, Ghori RA, Memon IA, Memon MA, Memon MS (2009) Serum zinc and magnesium in type-2 diabetic patients. J Coll Phys Surg Pak 19:483–486

    Google Scholar 

  77. Karamouzis MV, Gorgoulis VG, Papavassiliou AG (2002) Transcription factors and neoplasia: vistas in novel drug design. Clin Cancer Res 8(5):949–961

    CAS  PubMed  Google Scholar 

  78. Jansen J, Karges W, Rink L (2009) Zinc and diabetes—clinical links and molecular mechanisms. J Nutr Biochem 20(6):399–417

    Article  CAS  PubMed  Google Scholar 

  79. Forte G, Bocca B, Peruzzu A et al (2013) Blood metals concentration in type 1 and type 2 diabetics. Biol Trace Elem Res 156:79–90

    Article  CAS  PubMed  Google Scholar 

  80. Chung JS, Franco RJS, Curi PR (1995) Renal excretion of zinc in normal individuals during zinc tolerance test and glucose tolerance test. Trace Elem Electrolytes 12:62–67

    Google Scholar 

  81. Watts DL (1999) Trace elements and glucose disorders. Trace Elem Inc Newsl 11(2):5–9

    Google Scholar 

  82. Salgueiro MJ, Krebs N, Zubillaga MB et al (2001) Zinc and diabetes mellitus: is there a need of zinc supplementation in diabetes mellitus patients? Biol Trace Elem Res 81(3):215–228

    Article  CAS  PubMed  Google Scholar 

  83. Wapnir RA (2000) Zinc deficiency, malnutrition and the gastrointestinal tract. J Nutr 130:1388–1392

    Google Scholar 

Download references

Acknowledgments

The authors are thankful to be supported by the research center, “Center of Female Scientific and Medical Colleges,” Deanship of Scientific Research, King Saud University, Riyadh, KSA.

Author information

Authors and Affiliations

  1. Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Kingdom of Saudi Arabia

    Farah Aziz Khan, Noura Al Jameil, Sadia Arjumand, Mohammad Fareed Khan, Hajera Tabassum, Samyah Alenzi, Sahar Subaie & Sabiha Fatima

  2. Department of Research and Seized, Saudi Food and Drug Authority, Element Analysis Unit, Riyadh, Kingdom of Saudi Arabia

    Naif Alenzi & Sereen Hijazy

Authors
  1. Farah Aziz Khan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Noura Al Jameil
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sadia Arjumand
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mohammad Fareed Khan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hajera Tabassum
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Naif Alenzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Sereen Hijazy
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Samyah Alenzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Sahar Subaie
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Sabiha Fatima
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Noura Al Jameil.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Khan, F.A., Al Jameil, N., Arjumand, S. et al. Comparative Study of Serum Copper, Iron, Magnesium, and Zinc in Type 2 Diabetes-Associated Proteinuria. Biol Trace Elem Res 168, 321–329 (2015). https://doi.org/10.1007/s12011-015-0379-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12011-015-0379-3

Keywords

Search

Navigation